Advanced Regenerative Medicine
Advanced Regenerative Medicine
Chronic pain is defined as pain that persists beyond the point where tissue healing should have occurred, generally three months or longer. What that clinical definition does not capture is what it actually does to a person: the narrowing of activity, the disrupted sleep, the escalating medication list, and the growing sense that the medical system has run out of things to offer.
At The Goswami Clinic in Newport Beach, CA, chronic pain is approached through regenerative cell therapy delivered under image guidance to the specific structures producing symptoms. Dr. Gaurav Goswami is triple board certified in Surgery, Interventional Radiology, and Regenerative Medicine, and has focused on regenerative medicine for more than 15 years.
Key Takeaways
- Chronic pain often involves multiple contributing structures rather than a single source, which is why single-target treatments frequently disappoint.
- The clinic offers autologous cell therapy using bone marrow derived and fat derived MSC and MUSE cells, as well as ethically sourced allogeneic cells.
- Cell therapy is studied for its anti-inflammatory and immunomodulatory properties, not solely for structural tissue replacement.
- Published research shows meaningful pain reduction in some patient groups and little to no benefit in others; the evidence is genuinely mixed and is presented that way below.
- The Goswami Clinic is a cash-pay practice and does not accept insurance or Medicare.
Contact Us
Contact Us
Why Does Chronic Pain Persist?
Acute pain is a signal. Chronic pain is often a system that has stopped responding proportionally to that signal. Several things are usually happening at once.
Persistent Structural Irritation
Degenerative change in a joint, disc, or tendon can maintain a continuous low-grade inflammatory stimulus. The tissue is not healing because the loading and the local environment have not changed.
Chronic Inflammation
Sustained inflammatory signaling within a joint or around a nerve keeps pain-sensitive tissue sensitized. This is a significant part of why regenerative therapy is studied in chronic pain at all: mesenchymal stem cells are investigated substantially for their immunomodulatory and anti-inflammatory effects rather than only for tissue regeneration.
Multiple Pain Generators
This is the point most often missed. A patient with chronic low back pain may have disc degeneration, facet arthritis, sacroiliac dysfunction, and nerve root irritation simultaneously. Treating one and leaving three untreated produces partial or temporary relief, which is a common story among patients who arrive here after years of interventions.
Central Sensitization
Over time the nervous system itself can amplify pain signaling, so that the intensity of pain no longer corresponds well to the degree of tissue damage. This is a real phenomenon and it is one reason why no injection-based therapy, regenerative or otherwise, should be presented as a complete answer to chronic pain.
How Is Chronic Pain Evaluated at The Goswami Clinic?
Evaluation begins with determining which structures are actually contributing, and in what proportion. History, physical examination, and personal review of your imaging are combined rather than treated as separate steps. Dr. Goswami’s background in diagnostic and interventional radiology means imaging is read directly against the clinical picture instead of accepted from a report summary.
This step determines everything downstream. Cell therapy delivered accurately to the wrong structure is still the wrong treatment.
Stem Cell Therapy for Chronic Pain
Mesenchymal stem cells, commonly abbreviated MSCs, are studied for several properties relevant to chronic pain: modulation of local inflammation, signaling effects on surrounding tissue, and interaction with the immune environment of a damaged joint or disc. Much of the current research interest centers on these signaling and anti-inflammatory effects rather than on the cells directly rebuilding lost tissue.
Cell Sources Used at The Goswami Clinic
The clinic works with both autologous cells, meaning cells taken from your own body, and allogeneic cells, meaning cells from a donor source.
- Autologous bone marrow derived MSC and MUSE cells, harvested from your own bone marrow
- Autologous fat derived MSC and MUSE cells, harvested from your own adipose tissue
- Allogeneic cells from ethically sourced donor material
MUSE cells, short for multilineage-differentiating stress enduring cells, are a subpopulation found within mesenchymal cell populations that has attracted research attention for its stress tolerance and differentiation characteristics. Research into MUSE cells is at an earlier stage than research into MSCs generally, and claims about them should be read with that in mind.
Which source is appropriate depends on your age, medical history, the tissue being targeted, and the results of your evaluation. Autologous harvesting requires an additional procedure step; allogeneic material does not. These trade-offs are discussed individually during consultation rather than resolved by a standing protocol.
What the Research Shows
Presenting this honestly requires acknowledging that the published evidence is mixed. It is genuinely encouraging in some contexts and genuinely unimpressive in others, and any clinic that presents only one side is not giving you what you need to make a decision.
A 12-month controlled trial published in Pain Physician in 2022 by Atluri and colleagues examined autologous bone marrow derived MSCs in patients with chronic low back pain from severe lumbar degeneration. What distinguishes this study is its approach: rather than targeting a single structure, treatment was directed at multiple spinal structures simultaneously, including discs, facet joints, nerve roots, and the sacroiliac joint, based on each patient’s symptom pattern. Clinically meaningful pain reduction was reported in roughly three quarters of patients at three months, two thirds at six months, and over half at twelve months, with reported reductions in opioid use. The authors themselves note the study’s limitations: it was single center and not randomized.
A 2022 systematic review and meta-analysis published in Stem Cells International by Long and colleagues pooled 28 randomized controlled trials covering nearly 1,500 participants with osteoarthritis. Pooled results showed reductions in pain scores at three months that were sustained at twelve months, with reductions in stiffness and improvement in physical function.
Set against that, a 2024 systematic review and meta-analysis published in Osteoarthritis and Cartilage examined 16 randomized trials of MSC therapy for chronic knee pain from osteoarthritis. That analysis concluded that at three to six months, MSC therapy probably produced little to no meaningful difference in pain or function compared with placebo, with the measured improvement falling below the threshold considered clinically important. It also noted a possible increase in adverse events, primarily joint pain and swelling.
Read together, these findings suggest that outcomes vary considerably by patient population, cell preparation, target structure, and how success is measured. Stem cell therapy is not a guaranteed treatment for chronic pain, and no one should present it as one. What it may offer is an option worth evaluating for specific patients whose situation fits the contexts where results have been more favorable.
Why Image Guidance Matters
Cells delivered to the wrong location do nothing. Many of the structures relevant to chronic pain, including discs, facet joints, the sacroiliac joint, and the regions around nerve roots, cannot be reliably reached by landmark palpation. Dr. Goswami delivers cell therapy under real-time image guidance with placement confirmed before delivery. This is a direct application of his interventional radiology training and it is one of the more meaningful distinctions between providers offering regenerative treatment in Orange County.
Chronic Pain Conditions We Treat
Chronic pain is a category, not a diagnosis. Treatment is directed at the specific condition producing it. Conditions addressed at the clinic include chronic low back pain and spinal degeneration, sacroiliac joint pain, and spinal stenosis.
For joint pain, the clinic treats osteoarthritis across multiple joints, chronic hip pain, shoulder pain, and chronic knee pain.
Chronic neck pain is addressed on our neck pain treatment page, and tendon and soft tissue pain is often approached with PRP therapy either alone or alongside cell therapy.
Is Cell Therapy an Alternative to Opioids or Surgery?
These are two different questions and they deserve separate answers.
On opioids: the Atluri trial described above reported reduced opioid use in the treatment group, and reducing reliance on long-term opioid therapy is a reasonable goal to discuss. But cell therapy is not a detoxification protocol and should not be approached as one. Any change to an existing opioid regimen must be managed with the prescribing physician.
On surgery: for patients with advanced structural collapse, significant instability, or progressive neurological deficit, surgery remains the appropriate recommendation and regenerative therapy is not a substitute for it. Where cell therapy may have a role is for patients earlier in the process, patients who are not surgical candidates, or patients who want to exhaust non-surgical options first. We will tell you which group we believe you are in, and patients who need a surgeon are told so.
Seek Prompt Medical Attention
Progressive weakness, loss of bowel or bladder control, numbness in the groin or inner thighs, unexplained weight loss with new pain, or pain accompanied by fever require urgent medical evaluation rather than a scheduled consultation.
Who May Be a Candidate?
- Pain persisting longer than three to six months despite conservative care
- Completed physical therapy without durable improvement
- Temporary relief from steroid injections that consistently fades
- Multiple contributing structures rather than one isolated problem
- A desire to explore non-surgical options before considering surgery
- Medical circumstances that make surgery less attractive
Candidacy is determined individually based on examination, imaging, medical history, and functional goals. Not everyone who inquires is an appropriate candidate, and we would rather say so at the consultation than after treatment.
What to Expect at The Goswami Clinic
Begin with a free phone consultation with a patient care coordinator. If appropriate, a full evaluation with Dr. Goswami follows, including examination and personal imaging review, after which a treatment plan is discussed including which cell source is appropriate for your situation. Procedures are performed on an outpatient basis under image guidance and most patients return home the same day. You can request a consultation here.
Any changes patients notice typically develop gradually over weeks to months rather than immediately. Follow-up and ongoing guidance are part of the care plan.
Cash-Pay Practice
The Goswami Clinic operates as a cash-pay practice. We do not accept insurance and we do not accept Medicare. Cell therapy is a significant investment, and treatment cost depends on which cell source is used, how many structures are targeted, and the scope of your individual plan. Specific pricing is discussed during consultation once the treatment plan is defined. We state the cash-pay position early so patients can make an informed decision before investing further time.
Questions to Ask Any Chronic Pain Clinic
Regenerative medicine is an area where marketing has frequently outpaced evidence, and patients in chronic pain are a vulnerable audience for overstated claims. The following questions apply whether or not you choose to be treated here, and any clinic should be able to answer all of them directly.
- What specific cells are used, and are they autologous or allogeneic?
- Where do the cells come from, and how is the source documented?
- How is delivery guided, and is placement confirmed before the cells are delivered?
- What does the published evidence actually show for my specific condition?
- Who performs the procedure, and what is their training?
- What happens if I do not respond to treatment?
A clinic that answers these questions with certainty rather than nuance is telling you something about how it handles evidence. Be particularly cautious of any guarantee of results.
About Dr. Gaurav Goswami
Dr. Gaurav Goswami founded The Goswami Clinic in Newport Beach in 2009. He is triple board certified in Surgery, Interventional Radiology, and Regenerative Medicine, with more than 23 years of post-fellowship clinical experience and over 15 years dedicated to regenerative medicine. He is the author of The Stem Cell Cure, holds a United States medical device patent, and serves as a Scientific Advisor to the American Society of Regenerative Medicine. Read more about the clinic here.
The clinic is located at 4425 Jamboree Road, Suite 120, Newport Beach, California, serving patients throughout Orange County including Irvine, Costa Mesa, Huntington Beach, Laguna Beach, and Corona del Mar, as well as patients traveling from across the United States and internationally.
Frequently Asked Questions About Chronic Pain Therapy
Can stem cell therapy cure chronic pain?
No. Stem cell therapy is not a cure for chronic pain and should not be presented as one. Published research shows meaningful improvement for some patient groups and little measurable benefit for others. It may be worth evaluating as one option among several, depending on what is causing your pain.
What is the difference between autologous and allogeneic stem cells?
Autologous cells come from your own body, harvested from bone marrow or fat. Allogeneic cells come from an ethically sourced donor. Autologous harvesting requires an additional procedure step; allogeneic material does not. Which is appropriate depends on your age, medical history, and the tissue being targeted.
What are MUSE cells?
MUSE stands for multilineage-differentiating stress enduring cells, a subpopulation found within mesenchymal cell populations that has drawn research interest for its stress tolerance and differentiation characteristics. Research into MUSE cells is earlier stage than research into MSCs generally.
How long does it take to notice a difference after cell therapy?
Changes patients report typically develop gradually over weeks to months rather than immediately. Response varies considerably between individuals, and some patients do not experience meaningful improvement.
Does stem cell therapy replace pain medication?
It is not a replacement protocol for pain medication and should not be approached as one. Some published research has reported reduced opioid use following cell therapy, but any change to an existing medication regimen must be managed with your prescribing physician.
Is chronic pain therapy at The Goswami Clinic covered by insurance?
No. The Goswami Clinic is a cash-pay practice and does not accept insurance or Medicare.
Schedule a Free Phone Consultation
If pain has persisted past the point where conservative care should have resolved it, and you want an honest assessment of whether cell therapy is a reasonable option for your situation, start with a free phone consultation with a patient care coordinator.
THIS NOTICE MUST BE PROVIDED TO YOU UNDER CALIFORNIA LAW. This physician performs one or more stem cell therapies that have not yet been approved by the United States Food and Drug Administration. You are encouraged to consult with your primary care provider before undergoing any stem cell therapy.